Cost Effectiveness of a Belatacept-Based Regimen in Kidney Transplant Recipients.

被引：0
|
作者：
Caccioppoli, V. [1 ,2 ]
MacLasco, A. [2 ]
Chan, K. [2 ]
Gandhi, R. [2 ]
LaBella, S. [2 ]
Somers, L. [2 ]
Rogers, C. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Dept Pharm, Boston, MA 02215 USA
[2] Northeastern Univ, Bouve Coll Pharm, Boston, MA 02115 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [1] Cost Effectiveness of a Belatacept-Based Regimen in Kidney Transplant Recipients (vol 13, pg 183, 2013)
    Caccioppoli, V.
    MacLasco, A.
    Chan, K.
    Gandhi, R.
    LaBella, S.
    Somers, L.
    Rogers, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (09) : 2508 - 2508
  • [2] Evaluation of a Belatacept-Based Immunosuppression Regimen in Kidney Transplant Recipients
    Brisku, R.
    Rudzik, K.
    Augustine, J.
    Eckardt, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S848 - S849
  • [3] Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients
    El Sakhawi, Karim
    Melica, Giovanna
    Scemla, Anne
    Bertrand, Dominique
    Garrouste, Cyril
    Malvezzi, Paolo
    Remy, Philippe
    Moktefi, Anissa
    Ingels, Alexandre
    Champy, Cecile
    Lelievre, Jean-Daniel
    Kheav, David
    Morel, Antoine
    Mokrani, David
    Attias, Philippe
    Grimbert, Philippe
    Matignon, Marie
    [J]. CLINICAL KIDNEY JOURNAL, 2021, 14 (08) : 1908 - 1914
  • [4] Belatacept-based therapy cost effective in kidney transplant
    [J]. Reactions Weekly, 2013, 1455 (1) : 3 - 3
  • [5] Belatacept-based, ATG-Fresenius-induction regimen for kidney transplant recipients: A proof-of-concept study
    Cicora, Federico
    Mos, Fernando
    Petroni, Jorgelina
    Casanova, Matias
    Reniero, Liliana
    Roberti, Javier
    [J]. TRANSPLANT IMMUNOLOGY, 2015, 32 (01) : 35 - 39
  • [6] Clinical Outcomes of Conversion from Calcineurin Inhibitor to Belatacept-Based Immunosuppression in Highly Sensitized Kidney Transplant Recipients.
    Sethi, S.
    Choi, J.
    Vo, A.
    Peng, A.
    Lim, K.
    Najjar, R.
    Jordan, S.
    Huang, E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 291 - 292
  • [7] Belatacept-based immunosuppression: A calcineurin inhibitor-sparing regimen in heart transplant recipients
    Launay, Manon
    Guitard, Joelle
    Dorent, Richard
    Prevot, Yoann
    Prion, Florent
    Beaumont, Laurence
    Kably, Benjamin
    Lecuyer, Lucien
    Billaud, Eliane M.
    Guillemain, Romain
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (02) : 553 - 563
  • [8] Clinical Outcomes of Kidney Transplant Recipients Switched to Belatacept Based Regimen
    Villicana, R.
    Peng, A.
    Kahwaji, J.
    Choi, J.
    Vo, A.
    Jordan, S.
    [J]. TRANSPLANTATION, 2014, 98 : 456 - 456
  • [9] Direct Comparison of Clinical Outcomes with Belatacept-Based Regimens to Calcineurin Inhibitors Among DCD and/or High KDPI Kidney Transplant Recipients.
    Rizvi, A.
    Kueht, M.
    Hussain, S.
    Fair, J.
    Ramirez, R.
    Gamilla-Crudo, A.
    Mujtaba, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1093 - 1093
  • [10] Clinical Outcomes of Kidney Transplant Recipients Switched to Belatacept Based Regimen
    Villicana, R.
    Peng, A.
    Kahwaji, J.
    Choi, J.
    Vo, A.
    Jordan, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 456 - 456
12345